Amdocs director Yvette Kanouff acquires $100,800 in ordinary shares

AGNC’s Book Value Fell 17% in One Quarter. Here’s Why I’m Still Not Worried About the 17.5%-Yielding Dividend Just Yet.

NASDAQ · Markets 26m ago

Arm vs. ASML: Which Technology Stock Is a Better Buy for 2027?

NASDAQ · Markets 28m ago

SentinelOne vs. Synopsys: Which Technology Stock Is a Better Buy for 2027?

NASDAQ · Markets 30m ago

Quantum Corp.: 3 Key Takeaways for Long-Term Investors

NASDAQ · Markets 39m ago

Lilly presents obesity drug trial results at ObesityWeek 2026

Investing.com · News 45m ago

Amylyx avexitide trial meets primary endpoint for hypoglycemia

Investing.com · News 45m ago

Amdocs director Amos Genish buys $149,730 in shares

Investing.com · News 49m ago

Nylim MacKay portfolio manager sells $46,266 in MMD shares

Investing.com · News 49m ago

Arista Networks vs. IBM: Which Technology Stock Is a Better Buy for 2027?

NASDAQ · Markets 49m ago

The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.

NASDAQ · Markets 52m ago